Life Sciences
-
What does the future hold for the Life Sciences supply chain?
The Life Sciences sector is facing a period of profound change and disruption. Recent legislation efforts in the US like “Protecting Our Pharmaceutical Supply Chain from…
Read more -
How a global research and manufacturing company achieves regulatory compliance
As a Contract Research and Manufacturing organization with over 330 clients around the globe, regulatory compliance is non-negotiable for Syngene…
Read more -
Introducing OpenText Content Cloud for Life Sciences
OpenText™ is thrilled to announce the launch of OpenText Content Cloud™ for Life Sciences, an innovative new offering that brings…
Read more -
What’s new in OpenText Documentum for Life Sciences Cloud Edition (CE) 20.2
Pharmaceutical and Life Sciences companies are in the public spotlight as they pursue advanced therapies and vaccines to combat the…
Read more -
How prepared are you for the EU MDR?
On May 26, 2020, the EU Medical Device Regulation (MDR) exited its transition period. There are still questions about how…
Read more -
Is this the year of the patient-centric business model for healthcare?
You can’t deliver tomorrow’s innovation if you’re still using yesterday’s business models. For Healthcare 4.0, that means designing services and…
Read more -
Top 5 Life Sciences predictions in 2020
With the patient taking center stage, digitization is gaining pace within Life Sciences. This blog looks at how digital technology…
Read more -
What’s new in Release 19.4 for OpenText Life Sciences Express
OpenText™ Life Science Express has a new name: OpenText™ Life Sciences Smart View. Learn about it here. If you work…
Read more -
Tackling the ‘inconvenient truth’ of AI in healthcare
The market is growing fast for Healthcare Artificial Intelligence (AI), estimated to reach over $8 billion by 2026. During this…
Read more -
What’s driving cyber crime in life sciences?
So far, 2019 has been the worst year ever for data breaches in the healthcare and Life Science sector. And…
Read more -
What’s new in OpenText Documentum for Life Sciences Release 16 EP7
Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new…
Read more -
What’s new in OpenText Documentum for Life Sciences EP6
A lot has happened in the Life Sciences industry since the last update to OpenText™ Documentum for Life Sciences in…
Read more -
Industry Guide to Life Sciences: How to boost data visibility and regulatory compliance
I recently joined OpenText™ as the global industry strategist for life sciences and for my first blog post, I want…
Read more -
Selecting the best AI-powered analytics software for Life Sciences in 2019
Artificial intelligence or AI is fast becoming a key technology for the life sciences field. Combined with advanced analytics, it…
Read more -
With a focus on seamless sharing across domains, OpenText Documentum for Life Sciences 16.4 takes a giant leap forward
When major acquisitions happen, market analysts, competitors, customers, and employees alike are watching closely to determine what’s next. In fact,…
Read more -
The Life Sciences MLR process
Medical Legal Review (MLR) has always been one of the most challenging and complex aspects of the marketing production process…
Read more -
Introducing OpenText Life Sciences Express – it’s simple
OpenText™ Life Science Express has a new name: OpenText™ Life Sciences Smart View. Learn about it here. Simplicity. That’s what…
Read more -
ISO identification of medicinal products (IDMP)
In a previous blog I looked at some of the EU regulations that are disrupting the Life Sciences sector. One…
Read more -
Regulatory Matters: EU regulatory change is coming fast in Life Sciences
The Life Sciences sector is used to constant regulatory change. However, the next few years are about to see major…
Read more
